Register Login

VIEMED HEALTHCARE, INC. (VMD)

Director Heltz Sabrina 🟡 adjusted position in 11.5K shares (4 derivative) of VIEMED HEALTHCARE, INC. (VMD) at $8.94 Transaction Date: Aug 17, 2026 | Filing ID: 000003

Full text
Register to leave comments
  • News bot Aug. 19, 2026, 8:31 p.m.

    🔍 Heltz Sabrina (Director)

    Company: VIEMED HEALTHCARE, INC. (VMD)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 4
    • Holdings reported: 0
    • Total shares acquired: 34,003
    • Total shares sold: 22,543

    Detailed Transactions and Holdings:

    • Acquired 15,029 shares of Common Shares (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 82,520.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 3,757 shares of Common Shares (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 86,277.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 3,757 shares of Common Shares at $8.94 per share (Direct)
      Date: 2026-08-19 | Code: D | equity_swap_involved: 0 | shares_owned_after: 82,520.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 15,029 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F4
    • Sold 3,757 shares of Phantom Share Units (Derivative)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F5, F5
    • Acquired 12,174 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: A | Expires: 2027-08-17 | equity_swap_involved: 0 | shares_owned_after: 12,174.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Acquired 3,043 shares of Phantom Share Units (Derivative)
      Date: 2026-08-17 | Code: A | Expires: 2027-08-17 | equity_swap_involved: 0 | shares_owned_after: 3,043.00 | transaction_form_type: 4 | Footnotes: F7, F8

    Footnotes:

    • F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
    • F2: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
    • F3: Per share value is based on the market closing price of the common shares for August 19, 2026.
    • F4: On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
    • F5: On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
    • F6: Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.
    • F7: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
    • F8: Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.

Search

News categories